SAN FRANCISCO—The investigational agent saxagliptin, which belongs to a new class of anti-diabetic drugs that is taken orally rather than by injection, is effective and safe in treatment-naïve, type 2 diabetics with inadequate glycemic control, new findings suggest.

SAN FRANCISCO—Heavy consumption of artificially sweetened beverages was associated with almost twice the risk of diabetes in a long-term, community-based prospective study, researchers reported here at the American Diabetes Association annual meeting.

PARIS—Older women undergoing surgery for stress urinary incontinence (SUI) fare as well as younger women with respect to perioperative results, but they experience worse two-year outcomes, researchers reported here during a poster session at the Fourth International Consultation on Incontinence.

SAN FRANCISCO—Dietary salt supplementation may reduce the antihypertensive effects of the angiotensin receptor blocker (ARB) telmisartan in patients with type 2 diabetes and hypertension, investigators reported at the 68th Scientific Sessions of the American Diabetes Association. The effect is independent of habitual sodium dietary status.

PARIS—Investigators are predicting a significant increase in the number of individuals with lower urinary tract symptoms (LUTS) over the coming decade.

PARIS—Data suggest that losing even a modest amount of weight using a simple behavioral intervention is an effective, short-term treatment for urinary incontinence (UI) in overweight or obese women.

PARIS—The severity of a patient's overactive bladder (OAB) symptoms prior to treatment with fixed-dose darifenacin (Enablex) has no effect on treatment response, researchers announced here at the Fourth International Consultation on Incontinence.

SAN FRANCISCO—Nephrologists should consider a switch to tacrolimus and mycophenolate mofetil (TacMMF) in diabetic patients undergoing clinical islet transplantation (CIT) who are unable to tolerate sirolimus, Canadian researchers said.

SAN FRANCISCO—New data suggest that group-based lifestyle interventions followed for longer than six years can postpone or prevent development of type 2 diabetes for up to 20 years.

SAN FRANCISCO—British researchers have endorsed U.S. guidelines stating that screening diabetic patients for renal disease should involve estimated glomerular filtration rate (eGFR) in addition to testing for albuminuria.